logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Ansun Biopharma, Inc.


USPTO Granted Patents = 14



Forward Citations = 61

Loading Chart...
Loading Chart...

6 inventors (with patents filed for the assignee):

goldMedal Michael P Malakhov (8 out of 15 patents)

silverMedal Fang Fang (7 out of 14 patents)

bronzeMedal Ronald D Moss (2 out of 2 patents)

4.  Ronald B Moss (2 out of 2 patents)

5.  Stephen Hawley (2 out of 2 patents)

6.  Tiejun Li (1 out of 1 patent)

7.  Ron Moss (1 patent)

8.  Mang Yu (10 patents)

9.  Michael Malakhov (0 patent)

10.  Michael Malakhov (0 patent)

11.  Michael Malakhov (0 patent)


14 patents:

1. 11697803 - Method of protein purification from (2023-07-11),
2. 11241486 - Treatment of Middle East respiratory syndrome coronavirus (2022-02-08),
3. 11191817 - Treatment of infection by human enterovirus D68 (2021-12-07),
4. 10583086 - Technology for preparation of macromolecular microspheres (2020-03-10),
5. 10525109 - Class of therapeutic protein based molecules (2020-01-07),
6. 10351828 - [object Object] (2019-07-16),
7. 10328128 - Treatment of infection by human enterovirus D68 (2019-06-25),
8. 10300116 - Treatment for BK polyomavirus infection (2019-05-28),
9. 9764007 - Class of therapeutic protein based molecules (2017-09-19),
10. 9700602 - Microparticle formulations for delivery to the lower and central respiratory tract and methods of manufacture (2017-07-11),
11. 9212353 - Class of therapeutic protein based molecules (2015-12-15),
12. 8722869 - Class of therapeutic protein based molecules (2014-05-13),
13. 8623419 - Technology for preparation of macromolecular microspheres (2014-01-07),
14. 8512710 - Class of therapeutic protein based molecules (2013-08-20),
Company Overview
Ansun Biopharma, Inc. is a biopharmaceutical company based in San Diego, California, focused on developing innovative therapies for patients with serious unmet medical needs. The company specializes in the research and development of novel biologics, particularly in the field of immunotherapy and targeted treatments for various cancers and infectious diseases. Ansun's commitment to advancing healthcare solutions is reflected in its dedication to harnessing cutting-edge technology and scientific expertise to improve patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Ansun Biopharma, Inc. USPTO Patent Assignee Logo
14 Patents

#389 in San Diego, CA

#5,318 in California

#22,319 in US

#42,249 in the World

San Diego, CA (US)
San Diego, CA, United States of America

Ansun Biopharma, Inc.

Forward Citations = 61

6 inventors:

goldMedal Michael P Malakhov (8 out of 15 patents)

silverMedal Fang Fang (7 out of 14 patents)

bronzeMedal Ronald D Moss (2 out of 2 patents)

4.  Ronald B Moss (2 out of 2 patents)

5.  Stephen Hawley (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ansun Biopharma, Inc.. Retrieved from https://idiyas.com/company/ansun-biopharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…